LYELL EPI-R

Welcome to the Brand page for “LYELL EPI-R”, which is offered here for Medical services, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, therapeutic regulation of immune cells; medical services for treatment of cancer;scientific and technological services and biological research and development relating thereto, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, therapeutic regulation of immune cells, in the field of cancer treatment, auto-immune diseases, and infectious diseases; scientific and technological services and biological research and development, research and development in the field of the treatment of cancer;.

Its status is currently believed to be active. Its class is unavailable. “LYELL EPI-R” is believed to be currently owned by “Lyell Immunopharma, Inc.”